Treventis Corporation
PrivateLast Round
Grant
Oct 18, 2022
Total Funding Raised
$8.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Treventis Corporation operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in October 2022.
Treventis Corporation is a biotechnology company that develops disease-modifying small molecule drugs for protein misfolding diseases like Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treventis Corporation Comparables
Compare Treventis Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oligomerix, Inc. | 88% | |
| WaveBreak Therapeutics | 84% | |
| Aquinnah Pharmaceuticals | 84% |
For institutional investors. Book with your work email.
Treventis Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 18, 2022 | ||||
| Grant | Sep 19, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Treventis Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
| BioAdvance Capital | Seed |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 82% MoM.
- May 20, 2026
Monthly visitors grew 84% MoM, from 785 to 1.4K.
For institutional investors. Book with your work email.
Treventis Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Treventis Corporation's valuation, stock price, and market status.
Is Treventis Corporation a public or private company?
Treventis Corporation is a private company.
What is the current stock price of Treventis Corporation?
Treventis Corporation is a private company, so its shares have no public market price. Caplight tracks Treventis Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Treventis Corporation worth (valuation)?
Valuation information for Treventis Corporation is not publicly available.
Can I buy Treventis Corporation stock?
Treventis Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Treventis Corporation's last funding round?
Treventis Corporation's most recent funding round was Grant on October 18, 2022.
Who are the main investors in Treventis Corporation?
Key investors in Treventis Corporation include BioAdvance Capital, Wellcome Trust.
Will Treventis Corporation IPO soon?
No public IPO plans have been announced for Treventis Corporation.
How can I track Treventis Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Treventis Corporation's shares on secondary markets.